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Abstract
The severity index is a new echocardiographic measure that is thought to be an accurate indicator
of aortic leaflet pathology in patients with AS. However, it has not been validated against cardiac
catheterization or Doppler echocardiographic measures of AS severity nor has it been applied to
patients with aortic sclerosis. The purposes of this study were to compare the severity index to
invasive hemodynamics and Doppler echocardiography across the spectrum of calcific aortic valve
disease, including aortic sclerosis and AS. 48 patients with aortic sclerosis and AS undergoing
echocardiography and cardiac catheterization comprised the study population. The aortic valve
leaflets were assessed for mobility (scale 1 to 6) and calcification (scale 1 to 4) and the severity
index was calculated as the sum of the mobility and calcification scores according to the methods
of Bahler et al. The severity index increased with increasing severity of aortic valve disease; the
severity indices for patients with aortic sclerosis, mild to moderate AS and severe AS were 3.38 ±
1.06, 6.45 ± 2.16 and 8.38 ± 1.41, respectively. The aortic jet velocity by echocardiography and the
square root of the maximum aortic valve gradient by cardiac catheterization correlated well with
the severity index (r = 0.84, p < 0.0001; r = 0.84, p < 0.0001, respectively). These results confirm
that the severity index correlates with hemodynamic severity of aortic valve disease and may prove
to be a useful measure in patients with aortic sclerosis and AS.
Background
Aortic stenosis (AS) and aortic sclerosis are common find-
ings in elderly patients, affecting 50% of those over the
age of 84 years [1]. Echocardiography provides an accu-
rate noninvasive assessment of disease severity and pro-
gression [2,3]. Studies have found that the presence of
aortic valve calcium is associated with increased disease
severity and predicts more rapid disease progression [4].
Bahler et. al. proposed that the severity index, a measure
of both aortic valve leaflet calcium and mobility, was an
accurate indicator of aortic leaflet pathology in patients
with AS [5]. However, this new echocardiographic score
has not been validated against cardiac catheterization
measures of AS severity. Moreover, this index has not been
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echocardiography in patients with aortic sclerosis. There-
fore, the purposes of this study were to compare the sever-
ity index to invasive hemodynamics and Doppler
echocardiography across the spectrum of calcific aortic
valve disease, including aortic sclerosis and AS.
Methods
A. Study population
48 patients with aortic valve disease (aortic sclerosis and
AS) identified by echocardiography with subsequent
referral for invasive hemodynamic assessment of AS sever-
ity comprised the study population. All patients were
referred for echocardiography by their treating physicians
after a systolic murmur was detected. Patients underwent
standard left and right heart catheterization for assess-
ment of AS severity within one month of the echocardio-
gram. The institutional review board of Harbor-UCLA
Research and Education Institute approved the study pro-
tocol. At the time of cardiac catheterization, information
was obtained regarding the presence of traditional cardio-
vascular risk factors, including hypertension, family his-
tory of premature coronary artery disease, hyperlipidemia,
smoking, and diabetes mellitus.
Patients were classified as having hypertension if they
were receiving anti-hypertensive medications or had
known but untreated hypertension (systolic blood pres-
sure >140 mm Hg or diastolic blood pressure > 90 mm
Hg). Family history of coronary artery disease was defined
as premature coronary artery disease (occurring in men
age less than 45 years and women age less than 55 years)
in a first-degree relative. Hyperlipidemia was defined as
use of cholesterol lowering medication or, in the absence
of cholesterol lowering medication use, as having a total
serum cholesterol >240 mg/dL. Smoking was defined as
the use of >10 cigarettes/day. Patients receiving insulin or
oral hypoglycemic agents were classified as having diabe-
tes mellitus.
B. Cardiac catheterization
Standard retrograde left and right heart catheterization
was performed to evaluate AS severity. The left ventricle
was entered by the retrograde approach. Left ventricular
and aortic pressures were measured simultaneously using
a 6 French pigtail catheter within the left ventricle, and a
second 6 French pigtail catheter positioned in the ascend-
ing aorta. Computer assisted measurements of the peak-
to-peak, maximum and mean gradients were obtained.
Cardiac output was measured by the Fick method. Aortic
valve area was calculated using the Gorlin equation [6].
Aortic sclerosis was defined as the presence of aortic valve
leaflet calcification or thickening (increased echogenicity)
and no restriction to leaflet excursion by echocardiogra-
phy and a maximum gradient by catheterization of less
than 15 mm Hg. Mild AS was defined as a maximum gra-
dient by catheterization of greater than 15 mm Hg and
less than 36 mm Hg. Moderate AS was defined as a maxi-
mum gradient by catheterization of greater than 36 mm
Hg and less than 64 mm Hg. Severe AS was defined as a
maximum gradient by catheterization of greater than 64
mm Hg. For the statistical analysis, patients with mild AS
and moderate AS were included as one group. Patients
could be grouped in similar categories using the aortic
valve area by the Gorlin equation (data not shown); how-
ever, the aortic valve area was not calculated for patients
with a maximum gradient by catheterization of less than
15 mm Hg.
C. Echocardiography
Doppler-echocardiography examinations were performed
on a Hewlett-Packard 77020 AC echocardiographic scan-
ner (Hewlett-Packard, Palo Alto, CA). The peak instanta-
neous transvalvular aortic jet velocity was determined by
interrogating the aortic valve with continuous wave Dop-
pler from multiple acoustic windows in order to obtain
the highest jet velocity. Mean Doppler velocities were cal-
culated by averaging the instantaneous Doppler gradients
throughout the ejection period using an on-line quantifi-
cation package. Three cardiac beats were averaged and the
spectral display velocity curve was traced by hand. Ana-
tomic measurements of the diameter of the left ventricular
outflow tract were made from the two-dimensional par-
asternal long-axis view, parallel and adjacent to the aortic
valve plane.
AS was defined as the presence of a peak instantaneous
transaortic jet velocity of ≥ 2.0 m/sec and restriction to
valve leaflet opening in the presence of normal left ven-
tricular systolic function. Patients with AS were further
classified as mild AS (transaortic jet velocity 2.0 to 3.0 m/
sec), moderate AS (transaortic jet velocity 3.0 to 4.0 m/
sec) and severe AS (transaortic jet velocity >4.0 m/sec) [2].
Aortic sclerosis was defined as the presence of aortic valve
leaflet calcium or leaflet thickening and a peak instantane-
ous transaortic jet velocity of < 2.0 m/sec.
The aortic valve leaflets were assessed for mobility and cal-
cification according to the methods described by Bahler
et. al. [5]. The aortic valve leaflets were assessed in both
the parasternal long- and short-axis views. Aortic leaflet
calcification was graded according to the scale: 1 = none,
2 = ≥1 localized area of increased reflectivity but no areas
of dense calcification, 3 = markedly increased reflectivity
(calcification) in one leaflet but equal to or less than grade
2 changes in other leaflets, 4 = markedly increased reflec-
tivity in 2 leaflets but equal to or less than grade 2 changes
in the third leaflet, 5 = moderately increased reflectivity in
all leaflets and 6 = severely increase reflectivity in all leaf-Page 2 of 6
(page number not for citation purposes)
Cardiovascular Ultrasound 2006, 4:12 http://www.cardiovascularultrasound.com/content/4/1/12lets. Leaflet mobility was graded according to the scale: 1
= normal leaflet mobility, 2 = restriction of only 1 leaflet
with normal mobility of the other leaflets or mild restric-
tion of all leaflets, 3 = marked restriction of 2 leaflets or
moderate restriction of all leaflets, and 4 = almost no
mobility of any leaflet. The calcification and mobility
scores were summed to yield the severity index.
C. Statistical analyses
Statistical analyses were performed using SAS v.6.12 (SAS
Institute, Cary, NC) or GraphPad Prism, Version 3.02
(GraphPad Software, Inc., La Jolla, CA). Comparisons
amongst the three groups (aortic sclerosis, mild to moder-
ate AS and severe AS determined by cardiac catheteriza-
tion) were done using one-way analysis of variance for
continuous variables (age, maximum aortic valve gradi-
ent, transaortic jet velocity, severity index) and likelihood
ratio chi-square for discrete variables (gender, hyperten-
sion, diabetes, hyperlipidemia, smoking, family history,
aortic valve calcium, aortic valve mobility). These were
overall tests to determine if any two groups differed from
one another. Because cardiac catheterization gradients
were not normally distributed, regression analysis with
this variable was performed using square root-trans-
formed values.
Results
A. Patient characteristics
For the 48 patients, the mean (± SD) age was 56.1 ± 9.6
years and 32 (67%) were male. The prevalence of cardio-
vascular risk factors was: hypertension 32 (67%), smoking
19 (40%), diabetes mellitus 17 (35%), hyperlipidemia 20
(42%), and family history of coronary artery disease 16
(33%). Twenty-eight patients had aortic sclerosis, 12 had
mild to moderate AS and 8 had severe AS.
B. Cardiac catheterization
For the entire group of patients, the maximum aortic valve
gradient was 26 ± 30 mm Hg. For patients with aortic scle-
rosis, mild to moderate AS and severe AS, the mean (± SD)
maximum aortic valve gradients were 7.0 ± 2.8, 30 ± 16
and 83 ± 24 mm Hg, respectively (Figure 1A). The square
root of the maximum aortic valve gradient by catheteriza-
tion correlated well with the severity index (r = 0.84, p <
0.0001, Figure 1B).
C. Echocardiography
For the entire group of patients, the mean (± SD) transaor-
tic jet velocity by echocardiography was 1.5 ± 0.4 m/sec.
For patients with aortic sclerosis, mild to moderate AS and
severe AS, the mean (± SD) transaortic jet velocities was
1.29 ± 0.27, 2.65 ± 0.70 and 4.54 ± 0.60 m/sec, respec-
tively. The severity index for the entire group of patients
was 5.0 ± 2.5. The severity index increased with increasing
severity of aortic valve disease and was significantly differ-
ent among each patient group; the severity indices for
patients with aortic sclerosis, mild to moderate AS and
severe AS were 3.38 ± 1.06, 6.45 ± 2.16 and 8.38 ± 1.41,
respectively (Figure 2A). Aortic jet velocity correlated well
with the severity index (r = 0.84, p < 0.0001, Figure 2B).
The severity index was significantly higher in patients with
Catheterization Gradient vs. Severity IndexFigure 1
Catheterization Gradient vs. Severity Index. A. Sever-
ity index as determined by cardiac catheterization for 
patients with aortic sclerosis (maximum gradient <16 
mmHg), mild to moderate AS (maximum gradient 16–64 
mmHg) and severe AS (maximum gradient >64 mmHg). The 
severity index increased with increasing severity of aortic 
valve disease and was significantly different between the 
three groups (p < 0.0001 by one-way analysis of variance 
[ANOVA]). B. Correlation of Catheterization Gradient with 
Severity Index. There was a strong correlation between 
square root-transformed maximum catheterization gradient 
and severity index (r = 0.84).Page 3 of 6
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pared to patients with a low maximum aortic valve gradi-
ent (≤16 mm Hg), 7.80 ± 1.78 and 3.63 ± 1.35,
respectively (Figure 3).
Discussion
The initial study describing the importance of aortic valve
calcium in patients with aortic valve disease was reported
by Waller et. al. in 1983 [7]. In this necropsy evaluation of
40 elderly patients, the authors found that the grade of
aortic valve calcium correlated with the severity of AS.
Rubler et. al. extended these observations by using
echocardiography to grade aortic valve calcium in 153
males with aortic valve disease [8]. The presence of mod-
erate to severe aortic valve calcium identified those with
severe AS confirmed by cardiac catheterization. The sever-
ity index was introduced by Bahler et. al. in 1999 as a new
echocardiographic measure of aortic leaflet pathology and
includes an assessment of both leaflet mobility and calci-
fication [5]. In this study, the authors found that the sever-
ity index was independently associated with more rapid
disease progression. However, their study included only
patients with AS (aortic valve area ≤ 2.0 cm2). In our cur-
rent study, we sought to validate this new echocardio-
graphic scoring method against both invasive and non-
invasive hemodynamic measures of aortic valve disease
severity. Also, we included patients with aortic sclerosis, as
well as patients with AS. The results show that, across the
spectrum of calcific aortic valve disease, the severity index
was correlated strongly with both the maximum aortic
valve gradient, as measured by cardiac catheterization,
and with the maximal transaortic jet velocity, as measured
by echocardiography.
An important limitation of this study is that it is cross-sec-
tional. Therefore, while it includes patients with lesser
degrees of calcific aortic valve disease, it cannot determine
whether the severity index provides useful prognostic
Severity Index in Patients with a Low (<16 mm Hg) and High (≥16 mm Hg) Maximum Aortic GradientFigu e 3
Severity Index in Patients with a Low (<16 mm Hg) 
and High (≥16 mm Hg) Maximum Aortic Gradient. 
The severity index was significantly higher in patients with a 
high maximum aortic valve gradient (>16 mm Hg) compared 
to patients with a low maximum aortic valve gradient (≤16 
mm Hg), 7.80 ± 1.78 and 3.63 ± 1.35, respectively (p < 
0.0001 by one-way [ANOVA]).
Doppler Echocardiography vs. Severity IndexFigur  2
Doppler Echocardiography vs. Severity Index. A. 
Severity index as determined by Doppler echocardiography 
for patients with aortic sclerosis (aortic jet velocity <2.0 m/
sec), mild to moderate AS (aortic jet velocity 2.0–4.0 m/sec) 
and severe AS (aortic jet velocity >4.0 m/sec). The severity 
index increased with increasing severity of aortic valve dis-
ease and was significantly different between the three groups 
(p < 0.0001 by one-way [ANOVA]). B. Correlation of maxi-
mum Doppler aortic jet velocity with Severity Index. There 
was a strong correlation between aortic jet velocity and 
severity index (r = 0.84).Page 4 of 6
(page number not for citation purposes)
Cardiovascular Ultrasound 2006, 4:12 http://www.cardiovascularultrasound.com/content/4/1/12i
nformation in these patients beyond that provided by
more traditional hemodynamic measures. However, one
retrospective study has reported that aortic valve thicken-
ing (a component of the severity index) is associated with
increased risk of progression to AS [9]. Validation of the
severity index as a prognostic marker for either future clin-
ical events or progression to AS, could be examined in
large, prospective studies that include serial echocardio-
grams.
Conclusion
In summary, these results confirm that the severity index
correlates with hemodynamic severity of aortic valve dis-
ease and may prove to be a useful measure in the evalua-
tion of patients with aortic sclerosis and AS.
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Table 2: Characteristics of patients based on severity of aortic valve disease.
Characteristic Aortic Sclerosis n = 28 Mild-Mod AS n = 12 Severe AS n = 8 p value
Age (years, mean ± SD*) 56 ± 8 56 ± 13 59 ± 10 0.37
Gender Male/Female 20/8 8/4 4/4 0.54
Hypertension, n (%) 20 (71%) 8 (67%) 4 (50%) 0.54
Diabetes Mellitus, n (%) 10 (36%) 5 (42%) 2 (25%) 0.74
Hyperlipidemia, n (%) 13 (46%) 4 (33%) 3 (38%) 0.72
Smoking, n (%) 12 (43%) 3 (25%) 4 (50%) 0.45
Family History of CAD, n (%) 11 (39%) 4 (33%) 1 (13%) 0.32
Maximum Aortic Valve Gradient by Catheterization
(mean ± SD*) (mm Hg)
7.0 ± 2.8 30 ± 16 83 ± 24 <0.0001
Transaortic Jet Velocity by Echocardiography,
(mean ± SD*) (m/s)
1.29 ± 0.27 2.65 ± 0.70 4.54 ± 0.60 <0.0001
Severity Index (0 to 12) (mean ± SD*) 3.38 ± 1.06 6.45 ± 2.12 8.38 ± 1.41 <0.0001
AV Ca (1–6) (mean ± SD*) 2.2 ± 0.78 4.1 ± 1.6 5.5 ± 0.76 <0.0001
AV Mobility (1–4) (mean ± SD*) 1.2 ± 0.43 2.4 ± 0.67 3.3 ± 0.49 <0.0001
CAD = coronary artery disease; AV Ca = aortic valve calcium; AV Mobility = aortic valve mobility; *SD = Standard Deviation
Table 1: Characteristics of entire study group.
Characteristic n = 48
Age (years, mean ± SD*) 56 ± 9.7
Gender, M/F 32/16
Hypertension, n (%) 32 (67%)
Diabetes Mellitus, n (%) 17 (35%)
Hyperlipidemia, n (%) 20 (42%)
Smoking, n (%) 19 (40%)
Family History of CAD, n (%) 16 (33%)
Transaortic Jet Velocity by Echocardiography, (mean ± SD*) 2.2 ± 1.3
Maximum Aortic Valve Gradient by Catheterization, (mean ± SD*) 26 ± 30
Severity Index, (mean ± SD*) 5.0 ± 2.5
AV Ca (1–6) (mean ± SD*) 3.3 ± 1.7
AV Mobility (1–4) (mean ± SD*) 1.8 ± 0.94
CAD = coronary artery disease; AV Ca = aortic valve calcium; AV Mobility = aortic valve mobility; *SD = Standard DeviationPage 5 of 6
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